viru
small
infecti
agent
contain
littl
bundl
gene
strand
gene
strand
either
rna
dna
may
surround
bya
shell
protein
unlik
bacteri
cell
freeliv
entiti
virus
util
host
cell
environ
propag
new
virus
newli
made
virus
leav
host
cell
sometim
kill
process
proceed
infect
cell
within
host
viru
infect
caus
mild
ill
cold
deadli
ill
bloodi
african
fever
virus
caus
lassa
fever
ebola
fever
retroviru
caus
acquir
immunodefici
syndrom
aid
exampl
spread
easili
threaten
peopl
life
health
sometim
swiftli
cure
vaccin
jassim
naji
viral
infect
becom
one
main
caus
morbid
mortal
worldwid
golean
et
al
sinc
virus
plenti
invas
strategi
strain
viru
uniqu
configur
surfac
molecul
work
like
key
lock
enabl
virus
enter
host
accur
fit
molecul
surfac
target
cell
jassim
naji
sinc
virus
host
intim
connect
design
effect
antivir
inhibit
viral
enzym
replic
without
affect
host
cell
prove
difficult
golean
et
al
chattopadhyay
et
al
public
health
measur
prophylact
vaccin
still
import
mean
societi
control
spread
viral
infect
advanc
molecular
biolog
revers
genet
past
two
decad
mani
virus
known
uniqu
featur
structur
replic
cycl
potenti
target
sinc
viral
enzym
crucial
diseas
progress
viru
replic
inhibitor
viral
enzym
desir
strategi
wellstudi
inhibitor
hiv
herp
simplex
viru
hsv
influenza
virus
target
host
cell
bind
betulin
acid
etc
uncoat
capsid
amantadin
deriv
pleconaril
replic
revers
transcriptas
inhibitor
like
zidovudin
abacavir
nevirapin
etc
integras
inhibitor
dna
rna
polymeras
inhibitor
acyclovir
cidofovir
ribavirin
etc
proteinas
involv
viral
polyprotein
precursor
assemblymatur
inhibitor
indinavir
ritonavir
rimantadin
etc
base
strategi
numer
compound
test
differ
virus
past
decad
still
less
licens
antivir
market
chattopadhyay
et
al
develop
viral
resist
toward
current
antivir
agent
enhanc
need
new
effect
compound
viral
infect
new
antivir
compound
current
undergo
either
preclin
clinic
evalu
perspect
find
new
interest
antivir
drug
promis
chattopadhyay
et
al
among
antivir
substanc
sever
natur
compound
isol
plant
use
tradit
medicin
accord
statist
natur
product
becom
one
main
resourc
new
drug
research
develop
past
two
decad
especi
treatment
infecti
diseas
approxim
antivir
drug
approv
natur
product
semisynthet
natur
product
analogu
synthet
compound
base
naturalproduct
pharmacophor
newman
cragg
drug
screen
plant
extract
led
evalu
vitro
antivir
activ
jassim
naji
mukhtar
et
al
addit
applic
new
technolog
method
high
throughput
screen
ht
molecular
biolog
greatli
increas
probabl
find
valuabl
new
bioactiv
plant
extract
compound
li
vedera
chapter
histori
natur
product
antivir
drug
main
vitro
model
use
discov
evalu
potenti
lead
compound
antivir
substanc
antivir
properti
phytochem
special
action
mechan
review
histori
medicin
plant
date
back
origin
human
civil
earth
mukhtar
et
al
earli
time
natur
product
directli
use
treatment
diseas
includ
viral
infect
diseas
natur
product
made
great
contribut
human
health
mani
activ
constitu
natur
determin
mechan
action
elucid
inhibitori
effect
medicin
plant
extract
replic
sever
virus
report
past
six
decad
plant
antiinfluenza
activ
evalu
boot
drug
compani
nottingham
england
plant
found
effect
influenza
virus
embryon
egg
chantril
et
al
antivir
activ
extract
grape
appl
strawberri
fruit
juic
hsv
polioviru
type
coxsackieviru
echoviru
report
konowalchuk
speir
b
british
colombian
medicin
plant
also
report
antivir
activ
show
signific
antivir
effect
corona
virus
respiratori
syncyti
viru
rsv
parainfluenza
viru
type
herpesviru
type
retaviru
mccutcheon
et
al
common
chines
herbal
medicin
detect
antivir
activ
hiv
plant
exhibit
antihiv
activ
lou
chines
herbal
medicin
screen
antivir
activ
sever
acut
respiratori
syndrom
associ
coronaviru
sarscov
show
potent
antivir
activ
li
et
al
addit
herp
simplex
viru
type
debiaggi
et
al
hiv
asr
bucar
vermani
garg
hepat
b
viru
hbv
huang
et
al
kwon
et
al
dengu
viru
parida
et
al
rei
et
al
emerg
viral
infect
associ
poxviru
sever
acut
respiratori
syndrom
sar
viru
kotwal
et
al
strongli
inhibit
variou
plant
extract
studi
util
either
water
solubl
alcohol
extract
medicin
plant
limit
effort
direct
toward
identif
activ
natur
ingredi
exhibit
antivir
effect
typic
exampl
tradit
plant
medicin
antivir
activ
shown
tabl
moreov
recent
studi
show
plant
extract
possess
antivir
potenti
viral
strain
resist
convent
antivir
agent
serkedjieva
tolo
et
al
challeng
modern
drug
discoveri
practic
thu
explor
natur
antivir
compon
medicin
plant
necessari
although
medicin
plant
use
throughout
world
howev
wide
usag
limit
china
india
japan
pakistan
sri
lanka
thailand
number
african
countri
howev
develop
countri
gradual
accept
usag
plantbas
natur
medicin
product
healthcar
system
england
outstand
perform
tcm
stubborn
diseas
skin
eczema
current
british
govern
appear
support
research
usag
tcm
therefor
intern
drug
market
tcm
rapidli
expand
especi
england
jiang
besid
natur
health
product
regul
canada
promulg
perform
phase
iii
clinic
trial
chines
medicin
danshen
drip
pill
america
also
import
step
toward
modern
plantbas
product
usag
healthcar
advanc
encourag
usag
modern
technolog
evidencebas
scientif
support
toward
promot
medicin
plant
associ
product
siow
et
al
rt
activ
assay
ad
lysat
microtit
plate
poli
nucleotid
chain
coval
bound
base
well
mix
bromodeoxyuridin
triphosph
brdutp
ad
plate
incub
h
sivapalasingam
et
al
plate
wash
termin
reaction
brdubind
antibodi
conjug
alkalin
phosphatas
ap
ad
incub
min
follow
second
wash
ap
substrat
pnitrophenyl
phosphat
ad
result
yellow
color
chang
measur
quantifi
amount
incorpor
brdutp
follow
addit
ap
substrat
plate
read
three
time
point
min
h
h
overnight
h
result
express
femtogram
rt
activityml
plasma
lower
limit
detect
fgml
result
calcul
use
exavir
load
analyz
softwar
automat
determin
amount
rt
activ
sampl
use
standard
curv
gener
dilut
known
amount
recombin
rt
result
also
given
unit
rna
equival
copiesml
use
convers
factor
deriv
swedish
cohort
compris
mainli
subtyp
b
viru
assay
precis
determin
duplic
five
sampl
assay
reproduc
determin
seven
sampl
run
differ
day
although
differ
dna
polymeras
distinct
function
substrat
affin
gener
mechan
action
similar
thu
studi
use
technic
principl
primer
extens
assay
employ
radioact
tag
lope
et
al
explor
use
fluoresc
primer
assay
dna
polymeras
activ
vitro
primer
extens
use
follow
mer
oligodeoxynucleotid
templat
oligo
dt
ttttttttttttttttttttttt
gtcgtgactgggaaaac
dcda
n
templat
cacacacacacacacacacacacgtcgtgactgggaaaac
underlin
sequenc
univers
primer
sequenc
fluoresceinlabel
primer
alpha
dna
montreal
canada
anneal
two
templat
presenc
mm
trishcl
ph
mm
nacl
heat
min
follow
cool
sever
hour
obtain
substrat
sinc
klenow
fragment
dna
polymeras
well
character
use
model
experi
maintain
condit
radioact
label
primer
experi
tusk
et
al
lestienn
et
al
could
assess
differ
set
klenow
activ
briefli
dna
polymeras
klenow
fragment
incub
plant
constitu
primertempl
substrat
nm
deoxynucleotid
mm
trishcl
ph
mm
dithiothreitol
bovin
serum
albumin
mm
mm
nacl
reaction
mixtur
incub
min
reaction
quench
addit
stop
solut
deioniz
formamid
mm
edta
ph
mgml
xylen
cyanol
mgml
bromophenol
blue
heat
min
place
ice
product
resolv
denatur
polyacrylamid
sequenc
gel
autom
alf
dna
sequenc
ge
healthcar
analys
deoxynucleotid
incorpor
carri
allelelink
softwar
version
ge
healthcar
standard
fluorimetr
assay
use
measur
influenza
viru
na
activ
substrat
munana
methylumbelliferyl
acid
cleav
na
yield
fluoresc
product
quantifi
reaction
mixtur
contain
test
compoundsextract
na
enzym
viru
suspens
mm
me
buffer
mm
ph
incub
min
incub
reaction
termin
addit
mm
naoh
fluoresc
quantifi
excit
wavelength
nm
emiss
wavelength
nm
inhibitori
concentr
defin
concentr
na
inhibitor
necessari
reduc
na
activ
rel
reaction
mixtur
contain
viru
inhibitor
liu
et
al
hemagglutin
assay
ha
quantit
hemagglutin
protein
virus
viral
famili
surfac
envelop
protein
abl
agglutin
stick
human
anim
red
blood
cell
rbc
bind
nacetylneuramin
acid
rbc
form
type
lattic
case
contrast
plaqu
assay
ha
give
measur
viral
infect
viru
replic
requir
assay
easi
simpl
rapid
method
appli
larg
amount
sampl
detail
condit
depend
type
viru
virus
bind
rbc
certain
ph
valu
other
certain
ionic
strength
test
compound
inhibit
viru
replic
thu
viral
titr
ha
valu
reduc
ha
inhibit
assay
employ
test
effect
test
compound
viru
adsorpt
target
cell
compound
solut
twofold
serial
dilut
pb
mix
equal
volum
influenza
viru
solut
incub
min
room
temperatur
solut
mix
equal
volum
chicken
erythrocyt
suspens
incub
min
room
temperatur
song
et
al
cell
viabil
determin
mtt
dimethylthiahiazo
method
liu
et
al
consecut
threefold
serial
dilut
compoundsextract
refer
compound
ad
cell
monolay
replic
blank
medium
use
control
day
incub
mtt
solut
mgml
phosphatebuff
salin
ad
well
plate
incub
h
allow
format
formazan
product
remov
medium
dimethyl
sulfoxid
dmso
ad
dissolv
formazan
crystal
min
content
well
homogen
micropl
shaker
optic
densiti
measur
micropl
spectrophotomet
wavelength
nm
median
cytotox
concentr
calcul
concentr
test
sampl
reduc
number
viabl
cell
untreat
control
maxim
noncytotox
concentr
mncc
defin
maxim
concentr
sampl
exert
cytotox
effect
result
viabl
cell
antivir
activ
test
compoundsextract
measur
cpe
inhibit
assay
liu
et
al
viral
suspens
ad
well
plate
contain
confluent
cell
monolay
incub
h
viru
solut
remov
consecut
threefold
serial
dilut
test
compoundsextract
refer
compound
ad
well
use
mncc
highest
concentr
infect
control
without
sampl
also
includ
plate
incub
humidifi
atmospher
h
cpe
assess
virusinduc
cpe
score
follow
cpe
cpe
cpe
cpe
cpe
reduct
viru
multipl
calcul
percentag
viru
control
viru
control
cpeexpcpeviru
control
cpe
respect
viru
control
estim
use
method
select
index
si
calcul
ratio
plaqu
inhibit
assay
confluent
monolay
mdck
cell
cultur
tissu
cultur
plate
infect
mixtur
approxim
pfuml
viru
min
viru
adsorpt
solut
remov
cell
wash
twice
prewarm
mem
medium
replac
overlay
medium
dmem
contain
trypsin
low
melt
agaros
without
serum
contain
test
compoundsextract
differ
concentr
incub
cultur
day
monolay
fix
formaldehyd
solut
min
agaros
remov
flow
water
stain
wv
crystal
violet
solut
plaqu
count
visual
examin
percentag
plaqu
inhibit
calcul
rel
control
without
sampl
requir
concentr
reduc
plaqu
number
calcul
regress
analysi
curv
gener
data
song
et
al
mdck
cell
grown
confluenc
infect
influenza
viru
moi
cultur
presenc
compoundsextract
variou
concentr
h
postinfect
cell
scrape
collect
centrifug
g
min
cell
pellet
wash
pb
twice
total
cellular
viral
rna
isol
pellet
use
rneasi
mini
kit
qiagen
follow
manufactur
protocol
firststrand
cdna
synthes
total
rna
omniscript
rt
kit
qiagen
use
specif
primer
pcr
reaction
perform
reaction
buffer
cdna
templat
pmol
primer
mm
dntp
extaq
polymeras
takara
amplif
condit
follow
min
cycl
min
min
cycl
respect
np
rna
chosen
detect
primer
sequenc
use
detect
viral
rna
tgg
att
ctc
gtt
cgg
tc
sens
tta
tga
caa
aga
aga
aataaggcg
antisens
use
intern
control
cellular
rna
primer
sequenc
ccc
gag
tcc
atc
acg
sens
gta
ccc
cat
tga
gca
cgg
antisens
revers
transcript
pcr
product
resolv
agaros
gel
stain
ethidium
bromid
song
et
al
elisa
assay
allow
detect
viral
antigen
antibodi
use
solidphas
assay
system
although
qualit
offer
rapid
sensit
specif
method
detect
gross
quantit
viru
absolut
quanit
possibl
seri
predetermin
viral
titr
use
get
elisa
read
match
unknown
sampl
calcul
estim
quantiti
viru
sampl
untreat
drugtreat
method
differenti
infecti
noninfecti
viru
particl
result
drug
affect
earlier
latter
stage
viral
replic
matur
may
understood
chattopadhyay
et
al
briefli
untreat
drugtreat
cell
infect
known
concentr
viru
adsorb
h
wash
incub
day
depend
virusinduc
cpe
viru
harvest
freezethaw
centrifug
supernat
dilut
sampl
diluent
use
elisa
experi
well
stripplat
coat
viru
specif
antibodi
control
test
sampl
ad
follow
h
incub
room
temperatur
conjug
contain
enzym
label
virusspecif
antibodi
wash
five
time
substrat
ad
incub
dark
min
room
temperatur
assay
employ
horseradish
peroxidas
alkalin
phosphatas
reaction
stop
stop
solut
kit
usual
absorb
read
taken
photometr
altern
drug
treatment
viru
infect
perform
format
instead
prepar
viru
supernat
quadrupl
monolay
microtitr
plate
overlaid
dilut
test
compound
follow
infect
viru
h
incub
monolay
fix
glutaraldehyd
pb
assay
protein
specif
viru
cell
surfac
elisa
perform
monoclon
antibodi
mab
specif
protein
correspond
viru
strain
protein
horseradish
peroxidas
conjug
bio
rad
hercul
ca
optic
densiti
measur
express
percentag
nondrugtr
virusinfect
cell
viru
control
concentr
caus
reduct
optic
densiti
valu
evalu
graphic
plot
select
index
si
determin
ratio
among
natur
antivir
agent
recent
investig
reconsid
interest
phytopolysaccharid
act
potent
inhibitor
differ
virus
martinez
et
al
section
illustr
varieti
antivir
polysaccharid
natur
sourc
sinc
aim
make
matter
access
drug
develop
typic
exampl
medicin
antivir
activ
shown
tabl
inhibitori
effect
polyanion
substanc
replic
hsv
virus
report
almost
five
decad
ago
shortli
identif
hiv
caus
agent
aid
heparin
sulfat
polysaccharid
found
potent
select
inhibitor
replic
cell
cultur
sinc
activ
spectrum
sulfat
polysaccharid
shown
extend
variou
envelop
virus
includ
hsv
vitro
karmakar
et
al
herold
et
al
human
cytomegaloviru
hcmv
baba
et
al
respiratori
syncyti
viru
influenza
b
viru
damont
et
al
human
hepatoma
talarico
et
al
potenti
antihiv
drug
candid
sulfat
polysaccharid
offer
number
promis
featur
polysulf
show
differenti
inhibitori
activ
differ
hiv
strain
suggest
mark
differ
exist
target
molecul
polysulf
interact
inhibit
cytopath
effect
hiv
also
prevent
hivinduc
syncytium
giant
cell
format
furthermor
experi
carri
sulfat
sampl
increas
molecular
weight
sulfat
cyclodextrin
differ
degre
sulfat
shown
antivir
activ
increas
increas
molecular
weight
degre
sulfat
duart
et
al
wang
et
al
karmakar
et
al
sugar
backbon
strictli
need
antihiv
activ
polysulf
sulfat
polym
compos
backbon
also
prove
highli
effici
antihiv
agent
vitro
yet
defin
structur
featur
may
also
play
import
role
studi
mechan
action
polysulf
appear
exert
antihiv
activ
shield
posit
charg
site
loop
viral
envelop
glycoprotein
necessari
viru
attach
cell
surfac
heparan
sulfat
primari
bind
site
specif
bind
occur
receptor
cell
huheihel
et
al
gener
mechan
also
explain
broad
antivir
activ
polysulf
envelop
virus
variat
viral
envelop
glycoprotein
region
may
result
differ
suscept
differ
envelop
virus
compound
interact
envelop
glycoprotein
efficaci
sulfat
polysaccharid
herp
simplex
viru
type
demonstr
vivo
rat
rabbit
huheihel
et
al
proteoglycan
seem
potenti
candid
antihsv
agent
proteoglycan
glpg
extract
purifi
mycelia
ganoderma
lucidum
ethanol
etoh
precipit
deaecellulos
column
chromatographi
display
antivir
activ
type
studi
action
mechan
suggest
glpg
inhibit
viral
replic
interf
earli
event
viral
adsorpt
entri
target
cell
liu
et
al
vivo
antivir
activ
partial
demonstr
fusco
et
al
vivo
experi
polysaccharid
extract
echinacea
purpurea
wide
consum
botan
product
indic
mice
infect
wsn
influenza
treat
e
purpurea
polysaccharid
extract
less
weight
loss
untreat
mice
similar
pulmonari
viral
titer
echinaceatr
mice
lower
system
pulmonari
kc
level
lower
system
level
follow
influenza
infect
suggest
e
purpurea
alter
clinic
cours
influenza
infect
mice
modul
cytokin
direct
antivir
activ
flavonoid
common
natur
product
wide
exist
plant
kingdom
flavonoid
includ
genistein
catechin
shown
reduc
infect
varieti
virus
affect
human
anim
includ
adenoviru
hsv
hiv
porcin
reproduct
respiratori
syndrom
viru
rotaviru
andr
et
al
current
result
mechan
action
underli
antivir
properti
suggest
combin
effect
viru
host
cell
flavonoid
report
affect
viru
bind
entri
replic
viral
protein
translat
format
certain
viru
envelop
glycoprotein
complex
viru
releas
andr
et
al
also
affect
varieti
host
cell
signal
process
includ
induct
gene
transcript
factor
secret
andr
et
al
although
enorm
promis
result
vitro
experi
vivo
result
partli
confirm
vivo
efficaci
miki
et
al
flavonoid
possess
antivir
properti
wide
rang
virus
vitro
vivocondit
see
tabl
fig
tea
polyphenol
green
tea
mainli
consist
catechin
epigallocatechin
gallat
egcg
epicatechin
gallat
ecg
epigallocatechin
egc
abil
inhibit
sever
differ
virus
evalu
among
catechin
egcg
ecg
found
potent
inhibitor
influenza
viru
replic
mdck
cell
cultur
effect
observ
influenza
viru
subtyp
test
includ
b
viru
demeul
et
al
howev
sensit
hemagglutin
inhibit
wide
differ
among
three
differ
subtyp
influenza
virus
test
quantit
rtpcr
analysi
reveal
high
concentr
egcg
ecg
also
suppress
viral
rna
synthesi
mdck
cell
wherea
egc
fail
show
similar
effect
song
et
al
similarli
egcg
ecg
inhibit
neuraminidas
activ
effect
egc
song
et
al
result
show
group
catechin
skeleton
play
import
role
observ
antivir
activ
wherea
trihydroxi
benzyl
moieti
play
minor
role
song
et
al
addit
egcg
potenti
use
adjunct
therapi
infect
williamson
et
al
greater
antihsv
activ
green
tea
catechin
inactiv
multipl
clinic
isol
bind
gb
gd
anoth
envelop
glycoprotein
appear
promis
candid
use
microbicid
reduc
hsv
transmiss
isaac
et
al
among
green
tea
chatechin
egcg
effect
ad
cell
transit
earli
late
phase
adenoviru
infect
suggest
egcg
inhibit
one
late
step
viru
infect
webster
et
al
worth
mention
veregen
catechin
prescript
drug
condyloma
treatment
approv
us
fda
suggest
medicin
plant
open
new
prospect
pharmaceut
industri
reuter
et
al
flavonoid
apigenin
luteolin
display
signific
vitro
antiinfluenza
viral
activ
isol
tradit
chines
medicin
plant
elsholtzia
rugulosa
hemsl
liu
et
al
structureact
relationship
sar
flavonoid
influenza
viru
neuraminidas
inhibitor
reveal
good
inhibitori
effect
function
essenti
presenc
glycosyl
group
greatli
reduc
na
inhibit
liu
et
al
abil
flavonoid
inhibit
activ
na
one
pathway
inhibit
replic
influenza
viru
find
provid
import
inform
exploit
util
flavonoid
na
inhibitor
influenza
treatment
report
rutin
activ
viru
glucopyranosid
inhibit
potent
orhan
et
al
baicalein
genistein
block
human
cytomegaloviru
hcmv
replic
concentr
significantli
lower
produc
cytotox
grow
stationari
phase
host
cell
studi
mechan
action
suggest
primari
mechan
action
baicalein
may
block
hcmv
infect
entri
primari
mechan
action
genistein
may
block
hcmv
immediateearli
protein
function
ever
et
al
flavonoid
orientin
vitexin
found
flower
chines
folk
medicin
trolliu
chinensi
bung
exhibit
potent
moder
antivir
activ
li
et
al
flavonoid
chrysosplenol
c
yield
green
aerial
part
australian
plant
pterocaulon
sphacelatum
labil
benth
hook
f
ex
f
muell
abil
inhibit
replic
rhinovirus
sempl
et
al
antivir
activ
quercetin
tradit
chines
medicin
houttuynia
cordata
evalu
use
cytopath
effect
cpe
reduct
method
assay
result
demonstr
possess
strong
antiinfluenza
viru
reduc
format
visibl
cpe
addit
inhibit
viru
replic
initi
stage
viru
infect
indirect
interact
viru
particl
therefor
find
provid
import
inform
util
influenza
treatment
choi
et
al
b
flavonoid
luteoforol
isol
hypericum
connatum
guttifera
use
southern
brazil
treatment
lesion
mouth
often
relat
acut
herpet
gingivostomat
display
antivir
activ
dna
viral
strain
ko
atcc
fritz
et
al
moreov
flavon
inhibitor
proteinas
brinkworth
et
al
therefor
flavonoid
structur
similar
compound
possess
antivir
properti
wide
rang
virus
vitro
vivo
condit
find
provid
import
inform
new
drug
design
exploit
util
treatment
viral
infect
besid
natur
organ
acid
also
possess
antivir
activ
three
acid
deriv
name
acid
caffeoylquin
acid
acid
isol
tradit
chines
medicin
plant
schefflera
heptaphylla
investig
antivir
activ
rsv
see
fig
li
et
al
b
acid
caffeoylquin
acid
exhibit
potent
antirsv
activ
valu
respect
plaqu
reduct
assay
antivir
action
acid
acid
specif
rsv
obviou
antivir
activ
influenza
flu
coxsacki
cox
herp
simplex
type
one
virus
li
et
al
b
studi
indic
dicaffeoylquin
acid
could
inhibit
rsv
directli
extracellularli
much
higher
concentr
seen
standard
assay
moreov
could
inhibit
rsv
attach
host
cell
could
protect
cell
rsv
infect
lower
concentr
data
suggest
compound
exert
antirsv
effect
via
inhibit
fusion
earli
stage
inhibit
fusion
end
rsv
replic
cycl
li
et
al
b
raoulic
acid
princip
ingredi
plant
raoulia
australi
hook
f
fig
choi
et
al
antivir
assay
use
cytopath
effect
cpe
reduct
method
show
raoulic
acid
possess
strong
antivir
activ
human
rhinoviru
valu
less
human
rhinoviru
valu
coxsacki
viru
valu
coxsacki
viru
valu
enteroviru
viru
valu
less
howev
compound
possess
antivir
activ
influenza
flu
apr
flu
aw
b
virus
moreov
antivir
activ
aqueou
extract
pure
compound
plantago
major
l
popular
tradit
chines
medicin
studi
seri
virus
name
herpesvirus
adenovirus
result
show
aqueou
extract
p
major
possess
slight
antiherp
viru
activ
wang
et
al
certain
pure
compound
exhibit
potent
antivir
activ
among
caffeic
acid
exhibit
strongest
activ
si
si
si
wherea
chlorogen
acid
possess
strongest
si
activ
wang
et
al
studi
conclud
pure
compound
p
major
possess
antivir
activ
mainli
deriv
phenol
compound
especi
caffeic
acid
mode
action
found
multipl
stage
postinfect
h
h
chiang
et
al
addit
chlorogen
acid
caffeic
acid
also
show
inhibitori
effect
hbv
hepat
b
viru
replic
fig
wang
et
al
alkaloid
exhibit
antivir
activ
vitro
vivo
naphthoindozidin
alkaloid
togeth
noxid
isol
aerial
part
cynanchum
komarovii
antivir
activ
tobacco
mosaic
viru
et
al
sophoridin
one
activ
constitu
extract
chines
medicin
herb
sophora
flavescen
exhibit
significantli
antivir
activ
coxsackieviru
vitro
primarili
cultur
myocardi
cell
vivo
balbc
mice
regul
cytokin
express
like
sophoridin
metabolit
mainli
respons
antivir
activ
zhang
et
al
anoth
alkaloid
lycorin
isol
lycori
radiat
possess
antisarscov
activ
fig
li
et
al
plant
saponin
group
natur
occur
triterpen
steroid
glycosid
includ
larg
number
biolog
pharmacolog
activ
compound
saponin
shown
vitro
vivo
experiment
test
system
last
decad
possess
broad
spectrum
biolog
pharmacolog
activ
section
summar
recent
advanc
concern
antivir
activ
saponin
antivir
activ
triterpen
saponin
isol
angal
arvensi
studi
vitro
sever
virus
includ
adenoviru
type
vaccinia
vesicular
stomat
polioviru
amoro
et
al
drug
found
inhibit
replic
polioviru
type
shown
inhibit
cytopath
effect
reduct
viru
product
action
due
virucid
effect
might
involv
inhibit
virushost
cell
attach
singl
cycl
experi
indic
saponin
interf
earli
late
event
herp
viru
replic
amoro
et
al
tibetan
herb
potentilla
anserina
l
wide
use
china
mani
thousand
year
treat
hepatitisb
bioassayguid
fraction
ethanol
extract
rhizom
led
isol
triterpenoid
saponin
ts
determin
acid
ester
fig
zhao
et
al
use
model
hbv
infect
compound
evalu
effect
hbv
antigen
express
cell
line
vitro
antihepat
b
viru
hbv
activ
peke
duckl
vivo
zhao
et
al
result
show
could
decreas
express
level
hbsag
hbeag
hbvdna
cell
cultur
antivir
studi
vivo
peke
duckl
also
demonstr
compound
inhibit
duck
hepat
b
viru
dhbv
dna
replic
zhao
et
al
applic
essenti
oil
possibl
therapeut
agent
diseas
gain
attent
due
variou
factor
grow
consum
prefer
inexpens
natur
tradit
medicin
also
effect
resist
bacteri
viral
strain
stimul
investig
bioactiv
properti
essenti
oil
section
summar
recent
advanc
concern
antivir
activ
essenti
oil
artemisia
arborescen
l
essenti
oil
show
signific
antivir
activ
herp
simplex
viru
type
sinico
et
al
peppermint
oil
essenti
oil
mentha
piperita
exhibit
high
level
virucid
activ
also
activ
acyclovir
resist
strain
schuhmach
et
al
essenti
oil
santolina
insulari
also
inhibit
viru
replic
vitro
schnitzler
et
al
antivir
activ
princip
due
direct
virucid
effect
de
logu
et
al
lemon
balm
oil
essenti
oil
melissa
officinali
capabl
exert
direct
antivir
effect
consid
lipophil
natur
essenti
oil
enabl
penetr
skin
high
select
index
essenti
oil
might
suitabl
topic
treatment
herpet
infect
schnitzler
et
al
wood
essenti
oil
cedru
libani
wide
use
tradit
medicin
lebanon
treatment
differ
infect
diseas
mainli
consist
himachalol
identifi
vitro
antivir
activ
fig
loizzo
et
al
essenti
oil
anis
hyssop
thyme
ginger
camomil
sandalwood
possess
virucid
activ
mainli
adsorpt
probabl
interact
viral
envelop
koch
et
al
camomil
oil
exhibit
high
select
index
seem
promis
candid
topic
therapeut
applic
virucid
agent
treatment
herp
genitali
koch
et
al
recent
year
stilben
wide
exist
natur
kingdom
attract
much
attent
variou
biolog
activ
includ
antimicrobi
anticanc
antiinflamm
hepatoprotect
hepatotox
liu
et
al
resveratrol
natur
compon
certain
food
grape
shown
antihsv
activ
vitro
vivo
fig
docherti
et
al
moreov
resveratrol
found
inhibit
varicellazost
viru
vzv
replic
dosedepend
revers
manner
docherti
et
al
two
oligostilben
dibalanocarpol
balanocarpol
isol
leav
hopea
malibato
exhibit
modest
hivinhibitori
activ
vitro
dai
et
al
besid
oligostilben
also
possess
antivir
effect
four
stilbenoid
includ
isorhapontigenin
shegansu
b
gnetupendin
b
gnetin
liana
gnetum
pendulum
gnetacea
exhibit
signific
vitro
antiinfluenza
viral
activ
mdck
cell
valu
action
mechan
mainli
influenza
neuraminidas
na
inhibitori
effect
see
fig
liu
et
al
addit
antivir
activ
sever
kind
natur
product
also
report
terpenoid
caesalmin
b
bonducellpin
seed
tradit
chines
medicin
plant
caesalpinia
minax
exhibit
inhibitori
activ
viru
vitro
cytopathogen
effect
cpe
reduct
assay
jiang
et
al
hippomanin
phyllanthu
urinaria
linnea
euphorbiacea
commonli
use
tradit
medicin
plant
orient
countri
exhibit
antivir
activ
infect
fig
yang
et
al
chrysophan
acid
isol
australian
aborigin
medicin
plant
dianella
longifolia
found
inhibit
replic
polioviru
type
picornavirida
vitro
fig
sempl
et
al
compound
inhibit
earli
stage
viral
replic
cycl
irrevers
virucid
effect
polioviru
particl
chrysophan
acid
signific
antivir
activ
five
virus
test
coxsackieviru
type
human
rhinoviru
type
picornavirida
envelop
virus
ross
river
viru
togavirida
herpesvirida
four
structurallyrel
anthraquinon
rhein
emodin
aloeemodin
also
test
activ
polioviru
type
sempl
et
al
none
four
compound
activ
chrysophan
acid
viru
result
suggest
two
hydrophob
posit
chrysophan
acid
molecul
methyl
group
attach
import
compound
activ
polioviru
sempl
et
al
recent
report
emodin
isol
root
rheum
tanguticum
possess
remark
antivir
activ
hsv
infect
vitro
vivo
xiong
et
al
thu
emodin
promis
agent
clinic
therapi
hsv
infect
besid
seven
new
homoflavonoid
glucosid
pedunculosumosid
isol
whole
plant
ophioglossum
pedunculosum
pedunculosumosid
c
exhibit
modest
activ
block
hbsag
secret
valu
respect
wan
et
al
increas
interest
drug
discoveri
natur
product
antivir
activ
phytochem
report
greatli
promot
new
drug
discoveri
develop
treatment
viral
infect
diseas
common
viral
diseas
still
fatal
new
viral
infect
emerg
worldwid
recent
year
current
avail
antivir
though
effect
expens
develop
countri
thu
develop
safe
effect
inexpens
antivir
drug
among
top
global
prioriti
sinc
mani
virus
yet
curabl
mortal
rate
still
high
exampl
hiv
hepat
tendenc
viral
mutat
drugresist
form
essenti
continu
search
use
novel
natur
antivir
agent
expect
prolong
efficaci
drug
therapi
recent
lot
attent
given
screen
variou
speci
medicin
plant
especi
antivir
activ
asr
et
al
jassim
naji
chattopadhyay
et
al
sinc
obviou
number
plant
extract
show
posit
result
seem
reason
conclud
probabl
mani
potenti
antivir
agent
character
activ
ingredi
reveal
use
compound
compound
belong
wide
rang
differ
structur
class
eg
coumarin
flavonoid
tannin
alkaloid
lignan
terpen
naphtho
anthraquinon
polysaccharid
protein
peptid
may
also
novel
phytochem
although
larg
number
new
compound
isol
medicin
plant
market
pharmaceut
product
sever
compound
undergo
variou
phase
clinic
trial
tradit
use
medicin
plant
treatment
infecti
diseas
viral
origin
therefor
justifi
conclus
activ
phytochem
provid
import
inform
develop
new
medicin
plant
product
control
threat
pose
pathogen
virus
